Literature DB >> 23860670

[Calyceal stones].

C Netsch1, A J Gross.   

Abstract

The natural course of untreated, asymptomatic calyceal calculi has not yet been clearly defined regarding disease progression and risk of surgical interventions. The decision for an active treatment of calyceal calculi is based on stone composition, stone size and symptoms. Extracorporeal shockwave lithotripsy (ESWL) has a low complication rate and is recommended by the current guidelines of the German (DGU) and European (EAU) Associations of Urology as a first-line therapy for the treatment of calyceal stones <2 cm in diameter. However, immediate removal of stones is not achieved with ESWL. The primary stone-free rates (SFR) after ESWL depend on stone location and stone composition and can show remarkable differences. Minimally invasive procedures, such as percutaneous nephrolitholapaxy and ureteroscopy are alternatives for the treatment of calyceal stones which have low morbidity and high primary SFR when performed in centres of excellence.

Entities:  

Mesh:

Year:  2013        PMID: 23860670     DOI: 10.1007/s00120-013-3239-9

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  40 in total

1.  Treatment of caliceal calculi.

Authors:  W Hübner; P Porpaczy
Journal:  Br J Urol       Date:  1990-07

2.  Mechanical percussion, inversion and diuresis for residual lower pole fragments after shock wave lithotripsy: a prospective, single blind, randomized controlled trial.

Authors:  K T Pace; N Tariq; S J Dyer; M J Weir; R J D'A Honey
Journal:  J Urol       Date:  2001-12       Impact factor: 7.450

3.  A prospective randomised trial comparing the modified HM3 with the MODULITH® SLX-F2 lithotripter.

Authors:  Pascal Zehnder; Beat Roth; Frédéric Birkhäuser; Silvia Schneider; Rolf Schmutz; George N Thalmann; Urs E Studer
Journal:  Eur Urol       Date:  2011-01-25       Impact factor: 20.096

4.  Preliminary results of a randomized controlled trial of prophylactic shock wave lithotripsy for small asymptomatic renal calyceal stones.

Authors:  F X Keeley; K Tilling; A Elves; P Menezes; M Wills; N Rao; R Feneley
Journal:  BJU Int       Date:  2001-01       Impact factor: 5.588

5.  Ultrasonographic versus fluoroscopic access for percutaneous nephrolithotomy: a randomized clinical trial.

Authors:  Abbas Basiri; Amir M Ziaee; Hamid R Kianian; Sadrallah Mehrabi; Hormoz Karami; Seyed M Hosseini Moghaddam
Journal:  J Endourol       Date:  2008-02       Impact factor: 2.942

6.  Retrograde ureteroscopy for renal stones larger than 2.5 cm.

Authors:  Julie M Riley; Laura Stearman; Scott Troxel
Journal:  J Endourol       Date:  2009-09       Impact factor: 2.942

7.  Ureteral access sheath provides protection against elevated renal pressures during routine flexible ureteroscopic stone manipulation.

Authors:  Brian K Auge; Paul K Pietrow; Costas D Lallas; Ganesh V Raj; Robert W Santa-Cruz; Glenn M Preminger
Journal:  J Endourol       Date:  2004-02       Impact factor: 2.942

8.  Does open stone surgery still play a role in the treatment of urolithiasis? Data of a primary urolithiasis center.

Authors:  Patrick Honeck; Gunnar Wendt-Nordahl; Patrick Krombach; Thorsten Bach; Axel Häcker; Peter Alken; Maurice Stephan Michel
Journal:  J Endourol       Date:  2009-07       Impact factor: 2.942

9.  Randomized trial of stone fragment active retrieval versus spontaneous passage during holmium laser lithotripsy for ureteral stones.

Authors:  Oscar Schatloff; Uri Lindner; Jacob Ramon; Harry Z Winkler
Journal:  J Urol       Date:  2010-01-25       Impact factor: 7.450

10.  Impact of preoperative ureteral stenting on stone-free rates of ureteroscopy for nephroureterolithiasis: a matched-paired analysis of 286 patients.

Authors:  Christopher Netsch; Sophie Knipper; Thorsten Bach; Thomas R W Herrmann; Andreas J Gross
Journal:  Urology       Date:  2012-10-18       Impact factor: 2.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.